DrugCite
Search

AUTOPEN INSULIN INJECTION PEN

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Autopen Insulin Injection Pen Adverse Events Reported to the FDA Over Time

How are Autopen Insulin Injection Pen adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Autopen Insulin Injection Pen, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Autopen Insulin Injection Pen is flagged as the suspect drug causing the adverse event.

Most Common Autopen Insulin Injection Pen Adverse Events Reported to the FDA

What are the most common Autopen Insulin Injection Pen adverse events reported to the FDA?

Hypoglycaemia
50 (6.83%)
Blood Glucose Increased
26 (3.55%)
Myocardial Infarction
26 (3.55%)
Blood Glucose Fluctuation
24 (3.28%)
Hyperglycaemia
24 (3.28%)
Death
19 (2.6%)
Condition Aggravated
17 (2.32%)
Pneumonia
17 (2.32%)
Cerebrovascular Accident
14 (1.91%)
Diabetic Ketoacidosis
13 (1.78%)
Weight Increased
12 (1.64%)
Show More Show More
Product Quality Issue
11 (1.5%)
Diabetes Mellitus Inadequate Contro...
10 (1.37%)
Renal Failure
10 (1.37%)
Hospitalisation
9 (1.23%)
Vomiting
9 (1.23%)
Weight Decreased
9 (1.23%)
Atrial Fibrillation
8 (1.09%)
Ketoacidosis
8 (1.09%)
Myalgia
8 (1.09%)
Wrong Drug Administered
8 (1.09%)
Angina Pectoris
7 (.96%)
Gastrointestinal Carcinoma
7 (.96%)
Fatigue
6 (.82%)
Hypoglycaemic Unconsciousness
6 (.82%)
Vision Blurred
6 (.82%)
Cardiac Disorder
5 (.68%)
Cataract
5 (.68%)
Drug Ineffective
5 (.68%)
Dyspnoea
5 (.68%)
Hyperhidrosis
5 (.68%)
Hypoglycaemic Coma
5 (.68%)
Malaise
5 (.68%)
Nausea
5 (.68%)
Renal Impairment
5 (.68%)
Staphylococcal Infection
5 (.68%)
Asthenia
4 (.55%)
Blood Glucose Decreased
4 (.55%)
Cardiac Failure
4 (.55%)
Cough
4 (.55%)
Diabetic Complication
4 (.55%)
Haematoma
4 (.55%)
Medication Error
4 (.55%)
Neoplasm Malignant
4 (.55%)
Oedema Peripheral
4 (.55%)
Sepsis
4 (.55%)
Arrhythmia
3 (.41%)
Cardio-respiratory Arrest
3 (.41%)
Cellulitis
3 (.41%)
Convulsion
3 (.41%)
Coronary Artery Bypass
3 (.41%)
Coronary Artery Disease
3 (.41%)
Dermatitis Allergic
3 (.41%)
Diabetic Coma
3 (.41%)
Endocarditis
3 (.41%)
Eye Operation
3 (.41%)
Fall
3 (.41%)
Gangrene
3 (.41%)
Gastric Ulcer Haemorrhage
3 (.41%)
Gastroenteritis Viral
3 (.41%)
Headache
3 (.41%)
Hypoaesthesia
3 (.41%)
Hypotension
3 (.41%)
Lower Respiratory Tract Infection
3 (.41%)
Muscle Spasms
3 (.41%)
Pain In Extremity
3 (.41%)
Palpitations
3 (.41%)
Peripheral Vascular Disorder
3 (.41%)
Prostate Cancer
3 (.41%)
Pulmonary Oedema
3 (.41%)
Spinal Fracture
3 (.41%)
Acidosis
2 (.27%)
Anaemia
2 (.27%)
Aphasia
2 (.27%)
Appendicitis
2 (.27%)
Arterial Occlusive Disease
2 (.27%)
Arthritis Infective
2 (.27%)
Blindness Unilateral
2 (.27%)
Blood Alkaline Phosphatase Increase...
2 (.27%)
Blood Pressure Increased
2 (.27%)
Bronchitis
2 (.27%)
Cardiac Arrest
2 (.27%)
Chest Pain
2 (.27%)
Cholecystectomy
2 (.27%)
Cholecystitis Infective
2 (.27%)
Cyst Removal
2 (.27%)
Dehydration
2 (.27%)
Diabetic Foot
2 (.27%)
Ecchymosis
2 (.27%)
Eye Haemorrhage
2 (.27%)
Furuncle
2 (.27%)
Gastric Ulcer Perforation
2 (.27%)
Gastrointestinal Neoplasm
2 (.27%)
Head Injury
2 (.27%)
Hunger
2 (.27%)
Hypoglycaemic Seizure
2 (.27%)
Impaired Healing
2 (.27%)
Inguinal Hernia
2 (.27%)
Injection Site Pain
2 (.27%)
Insomnia
2 (.27%)
Ischaemic Stroke
2 (.27%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Autopen Insulin Injection Pen, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Autopen Insulin Injection Pen is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Autopen Insulin Injection Pen

What are the most common Autopen Insulin Injection Pen adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Autopen Insulin Injection Pen, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Autopen Insulin Injection Pen is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Autopen Insulin Injection Pen According to Those Reporting Adverse Events

Why are people taking Autopen Insulin Injection Pen, according to those reporting adverse events to the FDA?

Type 2 Diabetes Mellitus
1

Autopen Insulin Injection Pen Case Reports

What Autopen Insulin Injection Pen safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Autopen Insulin Injection Pen. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Autopen Insulin Injection Pen.